Titles

  • 03/2019-present. – Affiliated researcher, Centre de recherche du CHUM (CRCHUM), Cancer Axis, Montreal (QC), Canada
  • 03/2019-present. – Research member, Montreal Cancer Institute (QC) Canada
  • 01/06/2016-present. – Full Clinical Professor, Department of Medicine, Université de Montréal
  • 2015-present. – Director of the Adrenal Gland Pathophysiology Laboratory, Translational Research Projects, Molecular Biology and Genetics, Centre de recherche du CHUM (CRCHUM), Montreal (QC), Canada
  • 04/2015-present. – Outpatient Clinician, Hypertension Clinic, Clinical consultations, investigation, research, treatment and teaching, Clinical, Research Institute of Montreal (CRIM), Quebec, Canada.
  • 04/2006-present. – Medical Director, Interdisciplinary Adrenal Cancers Team, Cancer Control Program, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal (QC), Canada.
  • 04/2005-present. – Associate Member of the Genetic Medicine Service, Clinical Consultations, Research and Treatment, Centre Hospitalier de l’Université de Montréal (CHUM), Université de Montréal (QC), Canada.
  • 07/2004-present. – Regular Researcher, CHUM Research Center (CRCHUM), Cardiometabolic Axis, Montreal (QC), Canada.
  • 09/2003-present. – Active member of the Endocrinology Department, Clinical Consultations, Research and Treatment, Centre hospitalier de l’Université de Montréal (CHUM), Quebec, Canada.

Research Angle

Dr. Bourdeau conducts translational research on adrenal gland tumors. Her research interests include the genetics of adrenal tumors and the role of the Wnt/beta-catenin signaling pathway in the development of adrenal gland tumors.

Laboratory Team

  • Adrenal Gland Pathophysiology Laboratory

Recent publications

  1. Parisien-La Salle S, Provencal M, Bourdeau I (2020). Chromogranine A in a new cohort of pheochromocytomas and paragangliomas: its usefulness at diagnosis and as an early biomarker of recurrences. Endocrine practice, Accepted October, 2020.
  2. Bourdeau I, Parisien-La Salle S, Lacroix A (2020). Adrenocortical hyperplasia: a multifaceted disease. Invited review Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101386. doi: 10.1016/j.beem.2020.101386. Epub 2020.
  3. Poirier J, Gagnon N, Terzolo M, Puglisi S, El Ghorayeb N, Calabrese A, Lacroix A, Bourdeau I (2020). Recovery of Adrenal Insufficiency Is Frequent After Adjuvant Mitotane Therapy in Patients With Adrenocortical Carcinoma. Cancers (Basel), 2020 Mar 10;12(3): 63.
  4. Gagnon N, Caceres K, Corbeil G, El Goyareb N, Ludwig N, Latour M, Lacroix A, Bourdeau I* (2018). Genetic Characterization of GnRH/LH- Responsive Primary Aldosteronism. J Clin Endocrinol Metab. 2018 Aug 1;103(8):2926-2935. doi: 10.1210/jc.2018-00087.
  5. Moramarco J, El Ghorayeb N, Dumas N, Nolet S, Boulanger L, Burnichon N, Lacroix A, Elhaffaf Z, Gimenez Roqueplo AP, Hamet P, Bourdeau I* (2017). Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1. Clin Endocrinol (Oxf). Mar;86(3):332-339.

Pubmed Page

https://pubmed.ncbi.nlm.nih.gov/?term=bourdeau+i

Email Address for application

isabelle.bourdeau@umontreal.ca

Biography

Isabelle Bourdeau is a Full Professor of Medicine at the Centre hospitalier de l’Université de Montréal (CHUM) and a researcher at the CHUM research center since 2004. She obtained her certification as a specialist in endocrinology and metabolism in 2000. She did post-doctoral training in genetics of endocrine tumors and adrenal gland diseases under the supervision of Dr. Stratakis at the National Institutes of Health, Bethesda, USA.

She has been funded by the FRQ-S since 2004 as a Junior and Senior Clinical Scientist. She conducts translational research on adrenal gland tumors. Dr. Bourdeau is the author of over 100 scientific articles and book chapters. She is the director of the interdisciplinary adrenal tumor team at the CHUM which is recognized by the Ministry of Health as a quaternary center in Quebec. Since 2009, she is the director of the adrenal gland tumor biobank at the CHUM.